SCHEMBL6290422

SCHEMBL6290422

CC(C)(C)OC(=O)NCCCC[C@@](N)(C(=O)Cc1c[nH]c2ccc(Br)cc12)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@@](N)(CCCCNC(=O)OC(C)(C)C)C(=O)Cc3c[nH]c4ccc(Br)cc34)cc2)c2ccc(NC(=O)[C@@](N)(CCCCNC(=O)OC(C)(C)C)C(=O)Cc3c[nH]c4ccc(Br)cc34)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 2/20 0.42
MTNR1A P48039 2/20 0.39
MTNR1B P49286 2/20 0.39
FPR3 P25089 4/20 0.37
FPR2 P25090 4/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
IDO1 P14902 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CYP1A2 P05177 1/20 0.35
NQO2 P16083 1/20 0.35
BCHE P06276 2/20 0.34
ACHE P22303 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7036790 0.92 TRPV1 (0.41) LMNAIDO1CYP1A2NQO2
SCHEMBL6290282 0.91 ANO1 (0.39) MTNR1AMTNR1BHTR1DHTR1BCA1
SCHEMBL6284135 0.90 MAPT (0.43) MTNR1AMTNR1BCYP1A2NQO2MEN1
SCHEMBL6287996 0.89 CTSL (0.41) CAMK2DLMNACA1CA2ACHE
SCHEMBL6287580 0.86 TRPM8 (0.47) MTNR1AMTNR1BHTR1DMEN1KMT2A
Hydrochloric Acid SCHEMBL6291015 0.85 HTR2A (0.40) MTNR1AMTNR1BFPR2HTR1DHTR1B
SCHEMBL6287290 0.82 GOT1 (0.42) CAMK2DLMNAMEN1KMT2AGOT1
SCHEMBL6291033 0.81 MAPT (0.45) CAMK2DLMNACYP1A2MEN1KMT2A
SCHEMBL6286711 0.80 CAMK2D (0.42) CAMK2DCA1CA2MEN1KMT2A
SCHEMBL6290830 0.80 MAPT (0.42) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK CAMK2D 3521/4885MTNR1A 270/4885MTNR1B 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.